Explaining Unsupervised Disease Staging in Huntington's Disease: Insights into Model Representations and Clusters

• URL: http://arxiv.org/abs/2606.07135v2
• Date: Tue, 09 Jun 2026 16:37:45 GMT
• Title: Explaining Unsupervised Disease Staging in Huntington's Disease: Insights into Model Representations and Clusters
• Abstract summary: Huntington's disease (HD) is a progressive neurodegenerative disorder that affects motor, cognitive, and behavioral functions.<n>Unsupervised machine learning approaches have demonstrated the ability to uncover disease progression trajectories.<n>We extend a previously proposed ML-based disease staging framework by applying an explainability analysis to the extracted feature representations and discovered disease stages.
• Score: 0.0
• License: http://creativecommons.org/licenses/by-nc-nd/4.0/
• Abstract: Huntington's disease (HD) is a progressive neurodegenerative disorder that affects motor, cognitive, and behavioral functions, where accurate characterization of disease progression remains essential to improve patient outcome and quality of life. Unsupervised machine learning (ML) approaches have demonstrated the ability to uncover disease progression trajectories and meaningful latent stages from longitudinal data; however, their limited interpretability restricts clinical trust and translation. We extend a previously proposed ML-based disease staging framework by applying an explainability analysis to the extracted feature representations and discovered disease stages. Applied to the Enroll-HD dataset, we first project the learned representations into a lower-dimensional space to intuitively assess whether the resulting clusters align with the progression of established clinical measures. We then use saliency maps to identify the clinical features that most strongly contribute to the learned embeddings over time. Finally, we train a surrogate classifier and apply SHAP to quantify feature importance for cluster assignments and to analyze which clinical variables drive transitions between disease stages. The explainability analysis indicates that the learned embeddings capture clinically meaningful disease structure, aligning with established motor and functional severity scores and exhibiting progressive deterioration across clusters. Within this analysis, SHAP reveals a stratification of disease stages, ranging from early cognitive-motor impairment to severe functional dependency, consistent with known clinical progression patterns, while also highlighting intra-stage variability.

Related papers

• Longitudinal Bayesian Learning of Continuous Disease Position across the Alzheimer's Disease Continuum [57.659917052892155]
  We propose a longitudinal Bayesian Learning framework that continuously estimates disease severity from longitudinal diffusion tensor imaging (DTI)<n>Experiments on the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort demonstrate that DCP consistently outperforms representative disease progression methods.<n>These results suggest that DCS provides a quantitative imaging-derived representation for continuous assessment of Alzheimer's disease progression.
  arXiv  Detail & Related papers  (2026-08-19T20:41:26Z)
• A Machine Learning-Based Framework for Discovering Huntington's Disease Stages: Integrating Graph Representation Learning and clustering to Uncover Progression Dynamics in Longitudinal Enroll-HD Dataset [1.9449105330280387]
  Huntington's disease (HD) is a progressive brain disorder that gradually affects movement, cognitive function, and behavior.<n>We developed an unsupervised machine learning framework based on dynamic graph representation learning to capture temporal relationships within and across patients.<n>We applied the framework to 302 individuals from the Enroll-HD cohort (1,477 visits, 44 clinical variables per visit; 80% manifest participants), enabling data-driven discovery of HD stages.
  arXiv  Detail & Related papers  (2026-06-04T14:04:04Z)
• From Static Risk to Dynamic Trajectories: Toward World-Model-Inspired Clinical Prediction [61.12883122613684]
  This Review focuses on intervention-aware disease trajectory modeling in clinical AI--methods estimating patient-specific longitudinal disease evolution and assessing trajectory changes under alternative treatments.<n>We organize the field around six linked components: three decision tasks (factual forecasting, counterfactual estimation, policy evaluation) and three data-generating mechanisms (disease evolution, treatment assignment, observation process) that determine identifiability.<n>We present the first unified framework bridging forecasting, counterfactual trajectories, and policy evaluation across discrete/continuous time, explicitly addressing treatment assignment, time-varying confounding, and observation bias.
  arXiv  Detail & Related papers  (2026-05-16T10:45:26Z)
• Multimodal Graph-based Classification of Esophageal Motility Disorders [73.90451172929117]
  Diagnosing esophageal motility disorders pose significant challenges due to the complexity of high-resolution impedance manometry data and variability in clinical interpretation.<n>This work explores the feasibility of a multimodal Machine Learning-based classification approach that combines HRIM recordings with patient-specific information and incorporates a graph-based modeling of esophageal physiology.
  arXiv  Detail & Related papers  (2026-05-13T14:52:12Z)
• Beyond Traditional Diagnostics: Transforming Patient-Side Information into Predictive Insights with Knowledge Graphs and Prototypes [55.310195121276074]
  We propose a Knowledge graph-enhanced, Prototype-aware, and Interpretable (KPI) framework to predict diseases.<n>It integrates structured and trusted medical knowledge into a unified disease knowledge graph, constructs clinically meaningful disease prototypes, and employs contrastive learning to enhance predictive accuracy.<n>It provides clinically valid explanations that closely align with patient narratives, highlighting its practical value for patient-centered healthcare delivery.
  arXiv  Detail & Related papers  (2025-12-09T05:37:54Z)
• Chain-of-Influence: Tracing Interdependencies Across Time and Features in Clinical Predictive Modelings [9.057609869168957]
  Chain-of-Influence (CoI) is an interpretable deep learning framework that constructs an explicit, time-unfolded graph of feature interactions.<n>We evaluate CoI on mortality and disease progression tasks using the MIMIC-IV dataset and a private chronic kidney disease cohort.
  arXiv  Detail & Related papers  (2025-10-10T22:20:51Z)
• Longitudinal Progression Prediction of Alzheimer's Disease with Tabular Foundation Model [2.693752235635378]
  This work introduces L2C-TabPFN, a method that integrates a longitudinal-to-cross-sectional (L2C) transformation with a pre-trained Tabular Foundation Model (TabPFN) to predict Alzheimer's disease outcomes.<n>L2C-TabPFN converts sequential patient records into fixed-length feature vectors, enabling robust prediction of diagnosis, cognitive scores, and ventricular volume.
  arXiv  Detail & Related papers  (2025-08-25T04:24:51Z)
• Dynamic Classification of Latent Disease Progression with Auxiliary Surrogate Labels [4.997489272248076]
  Disease progression prediction based on evolving health information is challenging when true disease states are unknown.<n>We develop an adaptive forward-backward algorithm with subjective labels for estimation.<n>Asymptotic properties are established, and significant improvement with finite samples is demonstrated.
  arXiv  Detail & Related papers  (2024-12-11T04:14:15Z)
• CTP:A Causal Interpretable Model for Non-Communicable Disease Progression Prediction [12.282670150417953]
  We propose a novel model called causal trajectory prediction (CTP) to tackle the limitation. CTP combines trajectory prediction and causal discovery to enable accurate prediction of disease progression trajectories. We evaluate the performance of the model using simulated and real medical datasets.
  arXiv  Detail & Related papers  (2023-08-18T06:58:31Z)
• Benchmarking Heterogeneous Treatment Effect Models through the Lens of Interpretability [82.29775890542967]
  Estimating personalized effects of treatments is a complex, yet pervasive problem. Recent developments in the machine learning literature on heterogeneous treatment effect estimation gave rise to many sophisticated, but opaque, tools. We use post-hoc feature importance methods to identify features that influence the model's predictions.
  arXiv  Detail & Related papers  (2022-06-16T17:59:05Z)
• Trajectories, bifurcations and pseudotime in large clinical datasets: applications to myocardial infarction and diabetes data [94.37521840642141]
  We suggest a semi-supervised methodology for the analysis of large clinical datasets, characterized by mixed data types and missing values. The methodology is based on application of elastic principal graphs which can address simultaneously the tasks of dimensionality reduction, data visualization, clustering, feature selection and quantifying the geodesic distances (pseudotime) in partially ordered sequences of observations.
  arXiv  Detail & Related papers  (2020-07-07T21:04:55Z)
• Learning Dynamic and Personalized Comorbidity Networks from Event Data using Deep Diffusion Processes [102.02672176520382]
  Comorbid diseases co-occur and progress via complex temporal patterns that vary among individuals. In electronic health records we can observe the different diseases a patient has, but can only infer the temporal relationship between each co-morbid condition. We develop deep diffusion processes to model "dynamic comorbidity networks"
  arXiv  Detail & Related papers  (2020-01-08T15:47:08Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.